Siegall Clay B

President and CEO, DirectorImmunome Inc. (IMNM) · full profile →Form 4 · filed Nov 25, 2024
Net Buying
Open-Market Buys
$962K
Open-Market Sells
$0
Net Open-Market Flow
$962K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 22, 2024Buy(P)34K$9.78$332K520K
Nov 21, 2024Buy(P)66K$9.54$630K486K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-027601) within minutes of acceptance. Every field above traces to the original document. Verify it directly: